The Jinling Cohort
Recruiting now
Conditions studied: Cancer, Multi Cancer Early Screening, Liquid Biopsy
In brief
The Jinling Cohort is a prospective, multicenter cohort study in which 15,000 eligible individuals aged 45-75 in Nanjing China will be enrolled.
Key facts
- Study ID
- NCT06011694
- Run by
- Nanjing Shihejiyin Technology, Inc.
- People needed
- 15000
- Starts
- 2022-06-15
- Expected to finish
- 2027-05-15
- Last updated by the study team
- 2023-08-25
Who can join
Age: 45 and older, up to 75. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 1、45-75 years of age; 2、Willing and able to undergo blood sample collection, health questionnaires and annual routine physical exams once a year for three consecutive years; 3、Residents in Nanjing; 4、Fully understand the study and able to provide a written informed consent
You may not qualify if…
- Pregnant women;
- Individuals who have history of cancer or current diagnosis of cancer;
- Individuals who have organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant;
- Individulas who have blood transfusion within 30 days prior to the blood draw;
- Individuals who have an acute infection or inflammation within 14 days prior to the blood draw;
- Individuals who have taken medication with anti-tumor effects within 30 days prior to the blood draw;
- Individuals who will not be able to comply with the protocol procedures judged by researchers
Where it is running
- Nanjing Jiangbei People's Hospital — Nanjing, Jiangsu, China (enrolling)
- The Fourth Affiliated Hospital of Nanjing Medical University — Nanjing, Jiangsu, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.